Printer Friendly

NanoViricides announces purchase of common stock by insiders.

M2 EQUITYBITES-January 22, 2015-NanoViricides announces purchase of common stock by insiders


Nanomaterials antiviral company NanoViricides (NYSE MKT:NNVC) said on Wednesday that its executives purchased 62,392 shares of its common stock in uncoordinated open market purchases during its open trading windows for insiders.

During the period 6 January 2015 and 13 January 2015, the company's co-founder, president and chairman Dr Anil Diwan and Dr Milton Boniuk, an independent member of the board of directors, separately purchased the common stock from the company in open market purchases.

The company stated that Dr Diwan purchased 37,392 shares and Dr Boniuk purchased 25,000 shares at open market prices ranging between USD2.54 and USD2.75.

((Comments on this story may be sent to

COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 22, 2015
Previous Article:Physicians Realty Trust concludes higher public offering of 18.98m common shares, including exercise of underwriters option.
Next Article:Millicom to launch Tigo Music in Tanzania.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters